FMA Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.32M | Sell |
22,326
-607
| -3% | -$35.9K | 0.49% | 67 |
|
|
2021
Q2 | $1.53M | Buy |
22,933
+74
| +0.3% | +$4.94K | 0.57% | 65 |
|
|
2021
Q1 | $1.44M | Sell |
22,859
-643
| -3% | -$40.6K | 0.45% | 81 |
|
|
2020
Q4 | $1.46M | Buy |
23,502
+128
| +0.5% | +$7.94K | 0.49% | 73 |
|
|
2020
Q3 | $1.41M | Buy |
23,374
+1,010
| +5% | +$60.9K | 0.56% | 62 |
|
|
2020
Q2 | $1.32M | Buy |
22,364
+453
| +2% | +$26.6K | 0.59% | 58 |
|
|
2020
Q1 | $1.22M | Sell |
21,911
-1,106
| -5% | -$61.6K | 0.66% | 51 |
|
|
2019
Q4 | $1.48M | Buy |
23,017
+6,209
| +37% | +$398K | 0.59% | 56 |
|
|
2019
Q3 | $852K | Buy |
+16,808
| New | +$852K | 0.37% | 81 |
|
|
2015
Q2 | $47K | Buy |
+703
| New | +$47K | 0.03% | 199 |
|
|
2013
Q3 | – | Sell |
-4,854
| Closed | -$217K | – | 173 |
|
|
2013
Q2 | $217K | Buy |
+4,854
| New | +$217K | 0.09% | 160 |
|